Prexton Therapeutics

14 chemin des Aulx
1228 Plan les Ouat Genf
Switzerland

Phone

prextontherapeutics.com

Contact

About Prexton Therapeutics

Recently founded in Geneva, Switzerland, Prexton Therapeutics is developing novel mGluR4 PAM series.

News about Prexton Therapeutics

26-Feb-2015 | business & finance

Prexton Therapeutics raises €8.7 million ($10 million) in a Series A round

Prexton Therapeutics announced the closing of a Series A financing of €8.7 million ($10 million) co-led by Sunstone Capital and Ysios Capital. MS Ventures ...

Read news

29-Jan-2013 | business & finance

Domain Therapeutics grants Prexton Therapeutics an exclusive option to license and develop mGluR4 PAMs for Parkinson’s disease

Domain Therapeutics S.A. announced that Domain Therapeutics grants Prexton Therapeutics an exclusive option to license and develop metabotropic glutamate ...

Read news

Show more news about Prexton Therapeutics